Medicinal Products

Švedska grenčica Riviera oralna otopina

Name Švedska grenčica Riviera oralna otopina
Marketing Authorisation Number HR-H-239663734
Active Substance Tekući ekstrakt iz mješavine biljnih droga pelinova zelen, korijen žutog srčanika, korijen ljekovite anđelike, mira, maslačkov korijen, podanak bijele kurkume, orahov list, iđirotov podanak, podanak uspravne petoprste, maruljina zelen, odoljenov korijen, kora cejlonskog cimetovca i kardamomov plod
ekstrakcijsko otapalo: etanol 48% V/V
Composition 100 ml oralne otopine sadrži 71,5 ml ekstrakta (kao tekući ekstrakt) (odgovara količini od 2,01 g mješavine biljnih droga) iz Artemisia absinthium L., herba (pelinova zelen), Gentiana lutea L., radix (korijen žutog srčanika), Angelica archangelica L., radix (korijen ljekovite anđelike), Commiphora molmol Engler, gummi-resina (mira), Taraxacum officinale Weber ex Wigg., radix (maslačkov korijen), Curcuma zedoaria (Christm.) Roscoe, rhizoma (podanak bijele kurkume), Juglans regia L., folium (orahov list), Acorus calamus L., rhizoma (iđirotov podanak), Potentilla erecta (L.) Raeusch., rhizoma (podanak uspravne petoprste), Marubium vulgare L., herba (maruljina zelen), Valeriana officinalis L., radix (odoljenov korijen), Cinnamomum verum J.S. Presl, cortex (kora cejlonskog cimetovca), Elettaria cardamomum (L.) Maton, fructus (kardamomov plod). (66/180/328/367/260/294/260/38/50/32/54/54/27 mg) Ekstrakcijsko otapalo: etanol 96,3 % V/V : voda (1:1). DER 1: 33-37.
Pharmaceutical Form oralna otopina
Manufacturer Riviera Pharma & Cosmetics GmbH, Tulln, Austrija
Marketing Authorisation Holder Riviera Pharma & Cosmetics GmbH, Holzhackerstrasse 1, Tulln, Austrija
Marketing Authorisation Date 17.05.2023
MA Period of Validity unlimited
MA Revocation Date 16.06.2025*
Classification Number UP/I-530-09/22-02/43
Registration Number 381-12-01/70-23-07
Prescription Medicinal product not subject to medical prescription
Distribution Supply through pharmacies (community) and non-pharmacy outlets
Advertising to general public allowed
ATC Code A09
Marketing status trajni prekid opskrbe
SmPC download
PL download
Public Assessment Report download

*Note

Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act (Official Gazette No. 76/13), only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.

Packaging

Back